Vicentra
Medical Equipment Manufacturing, Surgical equipment and instruments, Health, medical and pharmaceutical · 51 Employees
Email Address: hello@hellokaleido.com
- Overview
- Job Postings
- Employees
Access 90 Verified Employees Profiles for VicentraUnlock Free Contacts Now
About
ViCentra BV, Medical Devices, Utrecht
Founded in 2013 in Utrecht, The Netherlands, ViCentra is a leading early stage commercial company focused on the development, manufacturing and commercialisation of the Kaleido insulin pump designed to help people with diabetes live life on their own terms.
Driven by our belief in the power of innovative healthcare products that put the people first and a desire to be meaningfully different, Kaleido aims to reduce the impact that diabetes can have on daily life.
Website
Year Founded
2013
Social Media
Linkedin
Industry
Medical Equipment Manufacturing, Surgical equipment and instruments, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Dental equipment and instruments, Equipment and instruments for medical laboratories, Medical equipment and instruments, Medische apparatuur en instrumenten, Gezondheid , medische en farmaceutische, Chemische producten, Farmaceutische producten en Kunststoffen
HQ Location
Rijnzathe 6
Utrecht, Utrecht Province 3454 PV, NL
Keywords
Medical Devices and Diabetes
Location
- Rijnzathe 6 Utrecht, Utrecht Province 3454 PV, NL
Email Formats
Sign up for free credits and discover verified email addresses of Vicentra
FormatExamples
first + last
andywarhol@hellokaleido.com
first_initial + last
awarhol@hellokaleido.com
first + last_initial
andyw@hellokaleido.com
first
andy@hellokaleido.com
last
warhol@hellokaleido.com
Frequently Asked Questions
Key Contacts
Similar Companies
Medical Equipment Manufacturing, Surgical equipment and instruments, Health, medical and pharmaceutical
Get key business info for Vicentra and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.